comparemela.com
Home
Live Updates
PepGen Announces Pricing of $80.1 Million Underwritten Offering of Common Stock : comparemela.com
PepGen Announces Pricing of $80.1 Million Underwritten Offering of Common Stock
BOSTON, Feb. 07, 2024 -- PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe...
Related Keywords
Boston ,
Massachusetts ,
United States ,
Sarah Sutton ,
Laurence Watts ,
Pepgen Inc ,
Exchange Commission ,
Syndicate Department ,
Leerink Partners ,
Frazier Life Sciences ,
Gilmartin Group ,
Nasdaq ,
Janus Henderson Investors ,
Laurion Capital Management ,
Monashee Investment Management ,
Octagon Capital ,
Perceptive Advisors ,
Enhanced Delivery Oligonucleotide ,
Markets ,
comparemela.com © 2020. All Rights Reserved.